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Abstract A monoclonal antibody (mAb) binding to protein C
(PC) heavy chain but not to activated PC was found to inhibit
PC activation by free thrombin, suggesting that epitope involved
the activation site. Using a set of overlapping synthetic peptides,
we confirmed that this mAb recognizes the sequence encompass-
ing the thrombin cleavage site (165QVDPRLI171). Surprisingly,
epitope was only accessible in the absence of calcium, half-
maximal inhibition of mAb binding occurring at 100 WM Ca2+.
Thus, our antibody provides direct evidence that conformation
and/or accessibility of the activation site differ between the apo
and Ca2+-stabilized conformers of PC.
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1. Introduction
Protein C (PC) is a precursor of a vitamin K-dependent
serine-protease [1]. It is composed of a light chain of 21
kDa and a heavy chain of 41 kDa, linked by a disul¢de
bridge. The light chain contains the Gla domain and two
domains homologous with epidermal growth factor (EGF).
The heavy chain contains the serine-protease domain, the cat-
alytic triad of which consists of Ser-360, His-211 and Asp-257
[2]. Thrombin cleaves PC after Arg-169, releasing a dodeca-
peptide at the N-terminal end of the heavy chain. In vivo, PC
activation requires thrombomodulin, an endothelial cell sur-
face protein acting as cofactor [3,4]. Activated PC (APC) lim-
its the coagulation process by inactivating factors Va and
VIIIa. This inactivation occurs through speci¢c proteolytic
cleavage in the presence of a negatively charged phospholipid
surface, Ca2 and protein S, the latter being a non-enzymatic
vitamin K-dependent protein that acts as cofactor.
Calcium ions are required for PC activation by the throm-
bin-thrombomodulin complex, whereas they have a strong
inhibitory e¡ect when thrombin alone is the activator, sug-
gesting a change in conformation at the cleavage site upon
calcium ion binding. Three types of Ca2 binding sites have
been identi¢ed in PC: (1) those of the Gla domain, involved
in the interaction with phospholipid surfaces [5]; (2) that of
the EGF domain which includes the L-hydroxy aspartate-71
and is involved in the interaction of PC with protein S, factor
Va, factor VIIIa and the thrombin-thrombomodulin complex
[6,7] ; and (3) that of the Ca2 binding loop encompassing
amino acids 225^235 in the serine-protease domain, which is
similar to that found in trypsin [8^11]. This 225^235 loop of
the serine-protease domain is the only Ca2 binding site re-
quired to inhibit activation by thrombin alone and rapid ac-
tivation by the thrombin-thrombomodulin complex. Its inter-
action with Ca2 induces a conformational change re£ected
by changes in intrinsic £uorescence attributable to Trp-231
and Trp-234 [12]. Occupancy of this site seems to correlate
with the inability of thrombin to activate PC in the presence
of Ca2.
Consistent with this hypothesis, we have characterized a
monoclonal antibody, 3H9E7, which recognizes the PC cleav-
age site only in the absence of Ca2.
2. Materials and methods
2.1. Reagents
Human thrombin was from Diagnostica Stago (AsnieØres, France);
recombinant desulfate hirudin variant 1 (TM Revasc) was a generous
gift from Dr. G.F. Pay (Ciba-Geigy, Basle, Switzerland); substrate S-
2366 (Glu-Pro-Arg-pNA) was from Chromogenix (Moºlndal, Sweden).
Horseradish peroxidase-labelled rabbit anti-human-PC polyclonal im-
munoglobulin was from Dako (Glostrup, Denmark). Horseradish per-
oxidase-labelled rabbit anti-mouse-IgG and bovine serum albumin
(BSA) were from Sigma (St. Louis, MO, USA). Nitrocellulose mem-
brane and alkaline phosphatase-conjugated goat anti-mouse IgG
polyclonal antibodies were from Bio-Rad (Hercules, CA, USA).
2.2. Preparation of monoclonal antibodies
Murine monoclonal antibodies (mAb) were prepared by bio-
MeŁrieux (Marcy l’Etoile, France). MAbs were selected, isolated and
characterized according to Koºhler and Milstein [13]. BALB/c mice
were immunized by intraperitoneal injections of 10 Wg of puri¢ed
PC emulsi¢ed in an equal volume of Freund’s complete adjuvant.
These injections were followed on days 28, 60 and 82 by injection
of the same quantity of antigen in Freund’s incomplete adjuvant.
Spleen cells isolated from immunized mice were fused with Sp2/o-
Ag 14 myeloma cells using polyethylene glycol. Culture supernatants
were screened in an ELISA method and positive colonies recognizing
immobilized human PC were cloned twice by the limiting dilution
technique. Ascitic £uid was obtained from mice primed by intraper-
itoneal injection of 0.5 ml of pristane and then injected with 106
hybridoma cells. The IgG1 subclass was determined by using a com-
mercial kit (Clonotyping System III, Fisher, Pittsburgh, PA, USA).
MAbs were puri¢ed from ascitic £uid by means of protein G-Sephar-
ose a⁄nity chromatography (Pharmacia LKB, Uppsala, Sweden).
2.3. Protein C puri¢cation and activation
Human plasma PC was immunopuri¢ed by using Sepharose-immo-
bilized mAb 10D1A3D11 (provided by Dr. Pittet, bioMeŁrieux). The
puri¢cation procedure was followed by anion-exchange chromatogra-
phy (MonoQ, Pharmacia LKB) using a CaCl2 gradient to elute PC.
Puri¢ed human PC (0.45 WM) was activated for 0^300 min at 37‡C by
human thrombin (18 U/ml) in Tris-20 mM HCl, 0.15 M NaCl, 10 mM
EDTA, bu¡er at pH 7.4. The amidolytic activity of the APC thus
generated was quanti¢ed by measuring the initial velocity (Vi) of
hydrolysis of substrate S-2366 (0.6 mM) at 405 nm on a microplate
reader connected to a computer (MR 5000, Dynatech Laboratories
Inc., Chantilly, VA, USA).
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2.4. ELISA assays
Polystyrene microtiter plates (Nunc Maxisorp) were coated over-
night at 4‡C with 130 Wl of 10 Wg/ml mAb 3H9E7 solution in 50 mM
sodium carbonate bu¡er pH 9. Plates were then washed thrice in Tris-
20 mM HCl-Tween bu¡er (TTBS). Samples diluted in 20 mM Tris,
150 mM NaCl bu¡er, pH 7.4, containing 10 mM EDTA or 0.1 to 2.5
mM CaCl2 were incubated in microplate wells (100 Wl) for 1 h at room
temperature. After three washes in TTBS, bound PC was measured by
adding 100 Wl of horseradish peroxidase-labelled rabbit anti-human
PC polyclonal immunoglobulin diluted 1:1000. After 1 h of incuba-
tion, 100 Wl of o-phenylenediamine (substrate) was added and the
reaction was stopped 10 min later by adding 50 Wl of 1 M H2SO4.
Absorbance was measured at 490 nm on a microplate reader (Dyna-
tech MR 5000).
2.5. Epitope mapping
Biotinylated peptides (14-mers, overlapping each other by 7-mers)
homologous to the PC heavy chain were synthesized by Chiron Mim-
otopes Pty (Clayton, Australia). Another set of 15 peptides (7^14-
mers) encompassing amino acids 161^174 was also synthesized. Mi-
crotiter plates (Nunc) treated with streptavidin (5 Wg/ml, Sigma) were
coated for 2 h at room temperature with each peptide diluted 1:1000
(5.5 WM). After three washes in PBS-Tween bu¡er and saturation with
5% bovine serum albumin (w/v, Sigma) for 2 h, plates were washed
thrice and incubated with mAb (50 nM in PBS) for 1 h. After three
washes bound mAb was measured by adding 100 Wl of horseradish
peroxidase-labelled rabbit anti-mouse IgG diluted 1:1000 (Sigma),
and then revealed.
2.6. Determination of the Kd of mAb 3H9E7 -PC interaction
Polystyrene microtiter plates (Nunc) were coated overnight at 4‡C
with 120 Wl of 62 nM PC solution in 50 mM sodium carbonate bu¡er,
pH 9. After ¢ve washes in PBS-Tween the plates were saturated with
200 Wl of 5% BSA (w/v) for 2 h at room temperature. After ¢ve
washes, 100 Wl of serial dilutions of mAb 3H9E7 was incubated for
1 h at room temperature. Bound mAb was revealed as described
above. The dissociation constant (Kd) of 3H9E7 for PC was estimated
by non-linear regression analysis of the A490 value as a function of the
3H9E7 concentration, using the following equation [14]:
A490  K Kd  Bmax  3H9E73Kd  Bmax  3H9E72
n
34UBmaxU3H9E71=2g 1
where Bmax is the apparent molar concentration of PC, and K is a
parameter such that the concentration of the PCW3H9E7 complex is
KUA490.
3. Results
Seven of the 10 mAbs binding to PC on immunoblots rec-
ognized the heavy chain of PC after reduction. The mAb
selected for this study (3H9E7) was one of the mAbs which
did not bind to APC in either reducing or non-reducing con-
ditions (Fig. 1), suggesting that epitope was lost after release
of the activation peptide.
To con¢rm interaction of 3H9E7 with the activation domain
of PC, the loss of mAb 3H9E7 binding to PC upon activation
by thrombin was examined by ELISA. APC formation was
determined at each time point in terms of the hydrolysis of a
chromogenic substrate. As shown in Fig. 2A, there was a
negative correlation between the amount of PC bound to
immobilized mAb 3H9E7 and the amount of APC generated.
Almost complete disappearance of the mAb/PC interaction
after 5 h showed that thrombin cleavage destroyed the mAb
epitope on the PC molecule. Concentration-dependent inhib-
ition of APC generation occurred when PC was incubated
with the mAb prior to activation by thrombin (Fig. 2B). Tak-
en together, these experiments strongly suggest that the epi-
tope was located in the activation domain.
The epitope appeared to be linear, as mAb 3H9E7 still
recognized the protein after denaturation and disul¢de bond
reduction. Using a bank of overlapping 14-mer peptides cor-
responding to the PC heavy chain sequence, we found that
mAb 3H9E7 recognizes two peptides only encompassing ami-
no acids 158^171 (DTEDQEDQVDPRLI) and 165^178
(QVDPRLIDGKMTRR). We then used a set of peptides en-
compassing the sequence DQEDQVDPRLIDGK (amino
acids 161^174) from which residues were deleted one by one
at the amino-terminus and carboxy-terminus (Fig. 3). The
minimal peptide sequence binding mAb 3H9E7 was
QVDPRLI (amino acids 165^171).
The e¡ect of Ca2 on PC binding to mAb 3H9E7 was ex-
amined by incubating PC in Ca2-depleted bu¡er or in bu¡er
containing increasing concentrations of Ca2 and the immo-
bilized mAb. As shown in Fig. 4, PC binding by the mAb
decreased as calcium ion concentrations increased, with half-
maximal inhibition at 100 WM. The mAb thus essentially rec-
ognized the activation domain in its Ca2-free conformation,
corresponding to the optimal conformation for free thrombin
activation. In our conditions, half-maximal inhibition of
thrombin activation was observed at 300 WM (not shown), a
value similar to that reported in the literature [5].
To determine the a⁄nity of 3H9E7 for PC, increasing con-
centrations of mAb were incubated with immobilized puri¢ed
PC in bu¡er containing EDTA. Analysis of the data by non-
linear regression according to Eq. 1 gave a Kd value of
0.55 þ 0.19 nM (Fig. 5), implying strong a⁄nity of the mAb
for PC. The binding curve was not in£uenced by the Ca2
concentration (not shown), indicating that Ca2 had no e¡ect
on mAb 3H9E7/PC interaction when the antigen was immo-
bilized on microplates. This might be due to the loss of cal-
cium binding site(s) in such a conformation. This experiment
also suggested that Ca2 binding by the mAb did not play a
major role in its interaction with PC. To rule out an in£uence
of Ca2 in the antibody reaction, we studied the e¡ect of Ca2
on mAb 3H9E7 binding to the immobilized peptide
DQEDQVDPRLIDGK, which encompasses the epitope.
There was no change in binding on exposure to Ca2 concen-
trations up to 1 mM (not shown).
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Fig. 1. Immunoblot analysis. PC (lanes 1 and 3) and APC (0.2 WM)
(lanes 2 and 4) were electrophoresed on 5% stacking and 10% sepa-
rating polyacrylamide slab gels in the presence of sodium dodecyl
sulfate (SDS-PAGE) in non-reducing (lanes 1 and 2) and reducing
(lanes 3 and 4) conditions, the latter in the presence of 4% L-mer-
captoethanol. After protein transfer to a nitrocellulose membrane,
the blot was allowed to react with mAb 3H9E7 (20 nM).
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4. Discussion
Many mAbs against PC are selected on the basis of their
calcium ion dependence, meaning that Ca2 ions are required
for the antibody-antigen interaction. Most recognize epitopes
located in the PC light chain, which bears Ca2 binding sites
in the GLA domain and the ¢rst EGF-like domain [15^17].
MAb HPC4, the epitope of which is a 12-residue peptide
encompassing the activation site, requires Ca2 to interact
with both the antibody domain and the PC target peptide
sequence [18].
In an attempt to map other epitopes, we selected mAbs
binding to PC on immunoblots after denaturation by SDS.
Seven recognized the PC heavy chain, and three of these in-
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Fig. 3. ELISA for 3H9E7 epitope mapping. Peptides (7^14-mers) en-
compassing the PC amino acid sequence 161^174 (DQEDQVDPR-
LIDGK) had their residues deleted one by one at the amino-termi-
nus or carboxy-terminus. Streptavidin-treated microplates were
coated with each of the peptides diluted 1:1000 (5.5 WM) as de-
scribed in Section 2 before addition of mAb 3H9E7 (50 nM in PBS)
and incubation for 1 h. Bars represent the binding of mAb to each
peptide, in terms of absorbance at 490 nm (A490). The amino acid
sequence of the control peptide was IKDFHVYFRESRDG.
Fig. 2. A: Time course of PC activation by thrombin and subse-
quent inhibition of PC binding to 3H9E7. Puri¢ed PC (0.45 WM)
was activated by thrombin (18 U/ml) in 20 mM Tris, 150 mM
NaCl, 10 mM EDTA. Aliquots were removed from the activation
mixture at 0, 15, 30, 45, 60, 120, 240 and 300 min and the reaction
was stopped by adding 130 U/ml hirudin. Amidolytic activity was
determined by adding 0.6 mM S-2366. Samples were diluted 1:4 in
Tris-20 mM HCl, 150 mM NaCl, 10 mM EDTA, pH 7.4 bu¡er and
added to 3H9E7-coated microplate wells (100 Wl). The graph repre-
sents the initial velocity Vi (b) of substrate hydrolysis (mA/s) and
absorbance at 490 nm in the ELISA assay (A490) (a) versus the ac-
tivation time. Mean of three duplicate experiments. B: E¡ect of
mAb 3H9E7 on PC activation by thrombin. Puri¢ed PC (0.31 WM)
was incubated with 3H9E7 (0^3.1 WM) for 15 min at 37‡C prior to
activation. PC was then activated with human thrombin (18 IU/ml)
for 120 min at 37‡C. The amidolytic activity of the APC thus gener-
ated was measured by monitoring hydrolysis of the substrate S-2366
(0.6 mM) at 405 nm on a microplate reader (Dynatech MR 5000).
The mAb/PC ratio is plotted against the amidolytic activity of gen-
erated APC (Vi : initial velocity of the substrate hydrolysis reaction
(mA/s)).
Fig. 4. E¡ect of calcium ions on PC/3H9E7 interaction. Samples
containing puri¢ed PC (10 nM) in Tris-20 mM HCl, 0.15 M NaCl,
pH 7.4 bu¡er containing 0^1 mM CaCl2 were incubated for 1 h at
room temperature. After washes, PC was detected as described in
Section 2. Absorbance was converted into bound PC from a stand-
ard curve based on serial dilutions of puri¢ed PC (0.62^10 nM) in
Tris-20 mM HCl, 0.15 M NaCl, pH 7.4 bu¡er pretreated with Che-
lex. Mean of three duplicate experiments.
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hibited PC activation by thrombin and recognized the same
peptide encompassing the thrombin cleavage site (data not
shown). Further studies were performed with one of the three
mAbs, designated 3H9E7. Several mAbs reacting with syn-
thetic peptides encompassing the cleavage site have already
been described [15^18], indicating that this domain probably
forms a loop at the surface of the molecule that can be
cleaved by thrombin, in keeping with computer models based
on known crystal structures of serine-proteases [19]. The min-
imal sequence recognized by 3H9E7 was 165QVDPRLI171,
showing the importance of Q-165 and I-171. As the aligned
sequence in mouse PC is EPDPRIV, the epitope is probably
QVXXXLI. In the crystal structure of activated PC, L-170
forms an ion pair with D-359, burying the new amino-termi-
nus in the core of the molecule and explaining the loss of
recognition of the epitope after cleavage by thrombin [20].
This property of mAb 3H9E7 may be useful for determining
whether puri¢ed PC concentrates can be fully activated.
One unique feature of mAb 3H9E7 is that it binds PC only
in the absence of Ca2. Interestingly, the concentration of
Ca2 required to inhibit its binding to PC was of the same
order as that inhibiting PC activation by thrombin (respective
half-maximal inhibitory concentrations of 100 and 300 WM).
This indicates that a conformational change occurs in the
activation domain upon Ca2 binding that prevents both rec-
ognition by mAb 3H9E7 and proteolytic attack by thrombin.
The high-a⁄nity Ca2 binding site important for PC activa-
tion is located within the serine protease domain and involves
a loop sequence encompassing amino acids 225^235 [8,12,21].
The present ¢ndings suggest that the QVDPRLI sequence in
the region of the scissile bond undergoes a conformational
change upon Ca2 binding to the calcium binding loop.
Ca2 binds neither to the activation peptide itself nor to the
antibody, as the QVDPRLI peptide alone bound the mAb
both in the presence and in the absence of Ca2. This con-
trasts with mAb HPC4, which binds the sequence EDQVPR-
LIDGK only in the presence of Ca2 [18]. Thus, mAb 3H9E7
provides us with a useful tool for PC immunopuri¢cation
from Ca2-free media. The only other anti-PC mAb displaced
from its epitope by Ca2 ions is H11, which recognizes a
sequence (FLEEXR/K) in the Gla domain that is shared by
several vitamin K-dependent coagulation proteins [22].
The sequence 165QVDPRLI171 is recognized in both dena-
tured PC and the synthetic peptide, implying that the epitope
is non-conformational and easily accessible in Ca2-free PC.
The loss of the PC/mAb interaction in the presence of Ca2
suggests a di¡erent structure or a di¡erent location of the
activation domain after occupancy of the Ca2 binding loop
in the serine protease domain. Several amino acids in the
vicinity of the P1-P1P bond, such as Asp-167 (P3), Pro-168
(P2) and Asp-172 (P3P), are also important for the adoption of
a calcium-dependent conformation precluding PC cleavage by
thrombin, as their mutation lifts the inhibitory e¡ect of Ca2
[10,23]. Replacement of these residues by Gly, Val and Gly,
respectively, seems to stabilize the conformation of the acti-
vation peptide in the absence of Ca2.
The release of mAb 3H9E7 on Ca2 binding to PC
provides direct evidence that a conformational change occurs
at the cleavage site in the Ca2-stabilized form of the mole-
cule.
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Fig. 5. Determination of the Kd of 3H9E7 for PC. Microtiter plates
were coated overnight at 4‡C with 60 nM puri¢ed PC. After
washes, serial dilutions of mAb 3H9E7 (0^6 nM) were incubated for
1 h at room temperature. Plot of A490 as a function of the total
3H9E7 concentration. The solid line represents the best ¢t to Eq. 1.
The estimated Kd value was 0.55 þ 0.19 nM; estimated PC concen-
tration less than 1 pM.
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